These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8271294)

  • 1. Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis.
    Scholl SM; Pallud C; Beuvon F; Hacene K; Stanley ER; Rohrschneider L; Tang R; Pouillart P; Lidereau R
    J Natl Cancer Inst; 1994 Jan; 86(2):120-6. PubMed ID: 8271294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M-CSF (monocyte colony stimulating factor) and M-CSF receptor expression by breast tumour cells: M-CSF mediated recruitment of tumour infiltrating monocytes?
    Tang R; Beuvon F; Ojeda M; Mosseri V; Pouillart P; Scholl S
    J Cell Biochem; 1992 Dec; 50(4):350-6. PubMed ID: 1334964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.
    Smith HO; Anderson PS; Kuo DY; Goldberg GL; DeVictoria CL; Boocock CA; Jones JG; Runowicz CD; Stanley ER; Pollard JW
    Clin Cancer Res; 1995 Mar; 1(3):313-25. PubMed ID: 9815987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colony-stimulating factor-1 and its receptor do not have a role in the pathogenesis of uterine sarcomas.
    Anderson PS; Smith HO; Goldberg GL; Fields AL; Runowicz CD; Pollard JW
    Gynecol Oncol; 1999 Aug; 74(2):202-7. PubMed ID: 10419732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status.
    Glajcar A; Szpor J; Hodorowicz-Zaniewska D; Tyrak KE; Okoń K
    Virchows Arch; 2019 Jul; 475(1):13-23. PubMed ID: 31016433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human breast cancer cells educate macrophages toward the M2 activation status.
    Sousa S; Brion R; Lintunen M; Kronqvist P; Sandholm J; Mönkkönen J; Kellokumpu-Lehtinen PL; Lauttia S; Tynninen O; Joensuu H; Heymann D; Määttä JA
    Breast Cancer Res; 2015 Aug; 17(1):101. PubMed ID: 26243145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of colony-stimulating factor receptor expression in ipsilateral breast cancer recurrence.
    Maher MG; Sapi E; Turner B; Gumbs A; Perrotta PL; Carter D; Kacinski BM; Haffty BG
    Clin Cancer Res; 1998 Aug; 4(8):1851-6. PubMed ID: 9717811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts.
    Paulus P; Stanley ER; Schäfer R; Abraham D; Aharinejad S
    Cancer Res; 2006 Apr; 66(8):4349-56. PubMed ID: 16618760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract.
    Kacinski BM
    Mol Reprod Dev; 1997 Jan; 46(1):71-4. PubMed ID: 8981366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot study.
    Scholl SM; Lidereau R; de la Rochefordière A; Le-Nir CC; Mosseri V; Noguès C; Pouillart P; Stanley FR
    Breast Cancer Res Treat; 1996; 39(3):275-83. PubMed ID: 8877007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CSF-1 treatment is effective to prevent carcinoma invasion induced by monocyte-derived cells but scarcely by microglia.
    Rietkötter E; Bleckmann A; Bayerlová M; Menck K; Chuang HN; Wenske B; Schwartz H; Erez N; Binder C; Hanisch UK; Pukrop T
    Oncotarget; 2015 Jun; 6(17):15482-93. PubMed ID: 26098772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10.
    Domínguez-Soto A; Sierra-Filardi E; Puig-Kröger A; Pérez-Maceda B; Gómez-Aguado F; Corcuera MT; Sánchez-Mateos P; Corbí AL
    J Immunol; 2011 Feb; 186(4):2192-200. PubMed ID: 21239715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of M-CSF and CSF-1R is correlated with histological grade in soft tissue tumors.
    Richardsen E; Sørbye SW; Crowe JP; Yang JL; Busund LT
    Anticancer Res; 2009 Oct; 29(10):3861-6. PubMed ID: 19846920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paracrine regulation of vascular endothelial growth factor--a expression during macrophage-melanoma cell interaction: role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor.
    Varney ML; Olsen KJ; Mosley RL; Singh RK
    J Interferon Cytokine Res; 2005 Nov; 25(11):674-83. PubMed ID: 16318581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the immune infiltrate and patient outcomes in esophageal cancer.
    Conroy MJ; Kennedy SA; Doyle SL; Hayes B; Kavanagh M; van der Stok EP; O'Sullivan K; Cathcart MC; Reynolds JV; Lysaght J
    Carcinogenesis; 2021 Apr; 42(3):395-404. PubMed ID: 32940666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM-CSF Production by Tumor Cells Is Associated with Improved Survival in Colorectal Cancer.
    Nebiker CA; Han J; Eppenberger-Castori S; Iezzi G; Hirt C; Amicarella F; Cremonesi E; Huber X; Padovan E; Angrisani B; Droeser RA; Rosso R; Bolli M; Oertli D; von Holzen U; Adamina M; Muraro MG; Mengus C; Zajac P; Sconocchia G; Zuber M; Tornillo L; Terracciano L; Spagnoli GC
    Clin Cancer Res; 2014 Jun; 20(12):3094-106. PubMed ID: 24737547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
    Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
    J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paracrine regulation of colony-stimulating factor-1 in medulloblastoma: implications for pathogenesis and therapeutic interventions.
    Papavasiliou AK; Mehler MF; Mabie PC; Marmur R; Qingbin S; Keating RF; Kessler JA
    Neurosurgery; 1997 Oct; 41(4):916-23. PubMed ID: 9316054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ cytokine production by breast cancer tumor-infiltrating lymphocytes.
    Camp BJ; Dyhrman ST; Memoli VA; Mott LA; Barth RJ
    Ann Surg Oncol; 1996 Mar; 3(2):176-84. PubMed ID: 8646519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.